Inato has developed a global clinical trial marketplace that connects pharmaceutical sponsors with community-based research sites, enhancing patient access to clinical trials. By streamlining site selection and enrollment processes, Inato addresses the limited participation opportunities for diverse patient populations, ultimately accelerating the pace of medical research.
Funding
$38.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical companies face challenges in identifying and engaging diverse clinical trial sites, leading to delays, increased costs, and limited representation of patient populations. Traditional reliance on large academic centers restricts access to broader patient demographics and hinders medical research.
Solution
Inato provides a global clinical trial marketplace that connects pharmaceutical sponsors with community-based research sites, expanding patient access to clinical trials. The platform streamlines site selection and enrollment processes, enabling sponsors to partner with a wider range of research sites and improve diversity in clinical trials. By leveraging data and technology, Inato helps sponsors identify and monitor community sites, ensuring reliable research and performance. The marketplace facilitates connections between sponsors and sites, offering opportunities for community sites to participate in trials and contribute to medical advancements.
Target Audience
Inato serves pharmaceutical sponsors seeking to diversify their clinical trials and community-based research sites looking to expand their research opportunities and patient access.
Features
- Global clinical trial marketplace connecting pharmaceutical sponsors with community-based research sites
- AI-driven site selection to match sponsors with appropriate research sites based on specialties and past performance
- Data collection and monitoring of site performance throughout trials to improve future recommendations
- Streamlined process for sites to express interest and get selected for trials
- Platform for sponsors to post clinical trial opportunities and access a diverse pool of research sites
- Support for community sites in identifying eligible patients, including those in complex cases like oncology
- Tools to help sponsors include a more representative patient population in their trials, aligning with FDA requirements for clinical trial diversity